Skip to main content
Equibles
PRME logo

PRME · Prime Medicine, Inc. · Share Buybacks

Track PRME — free

Use PRME with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRME.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.12 +0.14 (+4.53%)
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 6, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, we concluded that substantial doubt exists about our ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 6, 2026
Market Cap
$525.99M
Shares
181.38M
Volume · Oct 5 2.01M Avg daily vol (3M) 3.19M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2023-11 $300,000,000 — —
Key facts CIK 1894562 CUSIP 74168J101 13F (30d) 3 filings 3 filers Visit website Investor relations